Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBluefield Solar Regulatory News (BSIF)

Share Price Information for Bluefield Solar (BSIF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.19%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 104.40
BSIF Live PriceLast checked at -
Bluefield Solar Income Fund is an Investment Trust

To provide Shareholders with an attractive return, principally in the form of quarterly income distributions by being invested primarily in solar energy assets located in the UK.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 Jul 2013 07:00

RNS Number : 8711J
Bluefield Solar Income Fund Limited
23 July 2013
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Bluefield Solar Income Fund LTD

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

BlackRock LBG DC 'A' Fund Asset Allocation Portfolio

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

12th July 2013

6. Date on which issuer notified:

18th July 2013

7. Threshold(s) that is/are crossed orreached: vi, vii

Holding has gone above 5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GG00BB0RDB98

N/A

N/A

7,300,000

7,300,000

N/A

5.60%

5.60%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

7,300,000

5.60%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

BlackRock Regulatory Threshold Reporting Team

14. Contact name:

Duncan Murray

15. Contact telephone number:

020 7743 3334

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUURVRORABUAR
Date   Source Headline
4th Oct 20234:31 pmRNSUpdate from QuotedData
2nd Oct 20234:47 pmRNSHolding(s) in Company
29th Sep 20237:00 amRNSDirector Retirement and New Audit Chair
28th Sep 20237:01 amRNSFourth Interim Dividend
28th Sep 20237:00 amRNSAnnual Report for the Year Ended 30 June 2023
13th Sep 20232:40 pmRNSHolding(s) in Company
5th Sep 20233:27 pmRNSHolding(s) in Company
24th Aug 202312:47 pmRNSDirector/PDMR Shareholding
23rd Aug 20235:03 pmRNSDirector/PDMR Shareholding
18th Aug 202312:10 pmRNSDirector/PDMR Shareholding
18th Aug 202312:08 pmRNSDirector/PDMR Shareholding
17th Aug 20233:58 pmRNSDirector/PDMR Shareholding
17th Aug 20237:00 amRNSUnaudited Net Asset Value as of 30 June 2023
7th Aug 202312:12 pmRNSThird Interim Dividend Announcement - Replacement
7th Aug 20237:00 amRNSThird Interim Dividend Announcement
22nd Jun 20237:00 amRNSRCF Increase and Extension
7th Jun 20237:00 amRNSConclusion of Audit Tender Process
18th May 20235:21 pmRNSChange to Director Roles and Responsibilities
11th May 20237:00 amRNSUnaudited NAV 31 Mar 2023 and 2nd Interim Dividend
2nd May 20237:00 amRNSRe-Financing, Increase & Extension of NatWest Loan
17th Mar 20239:44 amRNSDirector Declaration
8th Mar 20237:00 amRNSChange of Registrar
28th Feb 20237:00 amRNSInterim Results to 31 December 2022
22nd Feb 20233:28 pmRNSDirector Retirement
6th Feb 20237:00 amRNSNotice of Interim Results
23rd Jan 20237:00 amRNSFirst Interim Dividend
12th Jan 202312:32 pmRNSUpdate research from QuotedData
9th Jan 20233:32 pmRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSAcquisition of 46.4MWp Solar Portfolio
8th Dec 20225:45 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:52 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSChange to Director Roles & Responsibilities
29th Nov 20224:32 pmRNSResult of AGM
22nd Nov 20227:00 amRNSSept 22 NAV, Autumn Statement & Development Update
1st Nov 20227:00 amRNSNotice of AGM
20th Oct 20222:20 pmRNSDirector/PDMR Shareholding
17th Oct 20223:01 pmRNSDirector/PDMR Shareholding
14th Oct 20224:27 pmRNSDirector/PDMR Shareholding
14th Oct 20222:03 pmRNSDirector/PDMR Shareholding
13th Oct 20225:02 pmRNSDirector/PDMR Shareholding
7th Oct 20221:37 pmRNSDirector Appointment
6th Oct 20221:57 pmRNSDirector/PDMR Shareholding
4th Oct 20221:59 pmRNSDirector/PDMR Shareholding
3rd Oct 20223:56 pmRNSDirector/PDMR Shareholding
30th Sep 20225:11 pmRNSDirector/PDMR Shareholding
30th Sep 20227:01 amRNSFourth Interim Dividend Announcement
30th Sep 20227:00 amRNSAnnual Report for the Year Ended 30 June 2022
29th Sep 20227:00 amRNSChange to Director Roles and Responsibilities
23rd Sep 20227:00 amRNSPromotion to the FTSE 250
23rd Sep 20227:00 amRNSPromotion to the FTSE 250

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.